Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al.

Poppelaars PBM, van Tuyl LHD, Boers M.

Ann Rheum Dis. 2019 Jul 8. pii: annrheumdis-2019-215863. doi: 10.1136/annrheumdis-2019-215863. [Epub ahead of print] No abstract available.

PMID:
31285259
2.

Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.

Turk SA, Rasch LA, van Schaardenburg D, Lems WF, Sanberg M, van Tuyl LHD, Ter Wee MM.

BMC Rheumatol. 2018 Jun 26;2:16. doi: 10.1186/s41927-018-0024-9. eCollection 2018.

3.

Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.

Poppelaars PB, van Tuyl LHD, Boers M.

Ann Rheum Dis. 2019 May;78(5):586-589. doi: 10.1136/annrheumdis-2018-214618. Epub 2019 Feb 26.

PMID:
30808623
4.

The relationship between remission and health-related quality of life in a cohort of SLE patients.

Tsang-A-Sjoe MWP, Bultink IEM, Heslinga M, van Tuyl LH, van Vollenhoven RF, Voskuyl AE.

Rheumatology (Oxford). 2019 Apr 1;58(4):628-635. doi: 10.1093/rheumatology/key349.

PMID:
30517706
5.

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project.

van Beers-Tas MH, Ter Wee MM, van Tuyl LH, Maat B, Hoogland W, Hensvold AH, Catrina AI, Mosor E, Stamm TA, Finckh A, Courvoisier DS, Filer A, Sahbudin I, Stack RJ, Raza K, van Schaardenburg D.

RMD Open. 2018 May 21;4(1):e000641. doi: 10.1136/rmdopen-2017-000641. eCollection 2018.

6.

The controversy of using PGA to define remission in RA.

van Tuyl LHD, Boers M.

Nat Rev Rheumatol. 2018 Mar 21;14(4):245. doi: 10.1038/nrrheum.2018.36. No abstract available.

PMID:
29559715
7.

Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.

Britsemmer K, van Schaardenburg D, Boers M, De Cock D, Verschueren P, Radner H, Smolen JS, van Tuyl LHD.

Clin Exp Rheumatol. 2018 May-Jun;36(3):362-370. Epub 2018 Feb 26.

PMID:
29533752
8.

Evaluating quality of care in rheumatoid arthritis: the patient perspective.

Mahmood S, van Oosterhout M, de Jong S, Landewé R, van Riel P, van Tuyl LHD.

RMD Open. 2017 Jun 29;3(1):e000411. doi: 10.1136/rmdopen-2016-000411. eCollection 2017. No abstract available.

9.

Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Rheumatology (Oxford). 2017 Sep 1;56(9):1586-1596. doi: 10.1093/rheumatology/kex223.

PMID:
28859326
10.

Rheumatoid arthritis: Remission - keeping the patient experience front and centre.

van Tuyl LHD, Boers M.

Nat Rev Rheumatol. 2017 Oct;13(10):573-574. doi: 10.1038/nrrheum.2017.139. Epub 2017 Aug 31. No abstract available.

PMID:
28855692
11.

Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.

Rasch LA, Boers M, Hill CL, Voshaar M, Hoogland W, de Wit M, Flurey C, Davis B, Hetland ML, Brahe CH, Gossec L, Wells GA, Tugwell P, Kuriya B, Goel N, Singh JA, Duarte C, Da Silva J, van Schaardenburg D, Proudman S, van Tuyl LHD; Working Group on the Patients’ Perspective on Remission in Rheumatoid Arthritis.

J Rheumatol. 2017 Dec;44(12):1889-1893. doi: 10.3899/jrheum.161111. Epub 2017 Aug 1.

PMID:
28765250
12.

Content Validity of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis.

Rasch LA, de van der Schueren MA, van Tuyl LH, Bultink IE, de Vries JH, Lems WF.

Calcif Tissue Int. 2017 Mar;100(3):271-277. doi: 10.1007/s00223-016-0221-8. Epub 2017 Jan 12.

13.

The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.

van Tuyl LH, Sadlonova M, Hewlett S, Davis B, Flurey C, Goel N, Gossec L, Heegaard Brahe C, Hill CL, Hoogland W, Kirwan J, Hetland ML, van Schaardenburg D, Smolen JS, Stamm T, Voshaar M, Wells GA, Boers M.

Ann Rheum Dis. 2017 May;76(5):855-861. doi: 10.1136/annrheumdis-2016-209835. Epub 2016 Nov 30.

PMID:
27903508
14.

Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):989-996. doi: 10.1002/acr.23112. Epub 2017 Jun 7.

15.

One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy.

Lems WF, Baak MM, van Tuyl LH, Lodder MC, Dijkmans BA, Boers M.

RMD Open. 2016 Sep 12;2(2):e000313. doi: 10.1136/rmdopen-2016-000313. eCollection 2016.

16.

The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis.

Konijn NP, van Tuyl LH, Boers M, van de Ven PM, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Lems WF, Nurmohamed MT.

Rheumatology (Oxford). 2016 Sep;55(9):1615-22. doi: 10.1093/rheumatology/kew221. Epub 2016 May 31.

PMID:
27247434
17.

Patient-Reported Outcomes in Rheumatoid Arthritis.

van Tuyl LH, Michaud K.

Rheum Dis Clin North Am. 2016 May;42(2):219-37. doi: 10.1016/j.rdc.2016.01.010. Epub 2016 Mar 17. Review.

PMID:
27133486
19.

Quality in rheumatoid arthritis care.

Mahmood S, Lesuis N, van Tuyl LH, van Riel P, Landewé R.

Best Pract Res Clin Rheumatol. 2015 Aug-Dec;29(4-5):664-79. doi: 10.1016/j.berh.2015.09.009. Epub 2015 Nov 7. Review.

PMID:
26697773
20.

Impact of Symptoms on Daily Life in People at Risk of Rheumatoid Arthritis.

van Tuyl LH, Stack RJ, Sloots M, van de Stadt LA, Hoogland W, Maat B, Raza K, van Schaardenburg D.

Musculoskeletal Care. 2016 Sep;14(3):169-73. doi: 10.1002/msc.1127. Epub 2015 Dec 17. No abstract available.

PMID:
26681409
21.

Patient-reported outcomes in core domain sets for rheumatic diseases.

van Tuyl LH, Boers M.

Nat Rev Rheumatol. 2015 Dec;11(12):705-12. doi: 10.1038/nrrheum.2015.116. Epub 2015 Sep 1. Review.

PMID:
26324860
22.

Effective Treatment for Rapid Improvement of Both Disease Activity and Self-Reported Physical Activity in Early Rheumatoid Arthritis.

Konijn NP, van Tuyl LH, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, Nurmohamed M, van Schaardenburg D, Lems WF.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):280-4. doi: 10.1002/acr.22668.

23.

Glucocorticoid safety for treating rheumatoid arthritis.

Rasch LA, Bultink IE, van Tuyl LH, Lems WF.

Expert Opin Drug Saf. 2015 Jun;14(6):839-44. doi: 10.1517/14740338.2015.1027681. Epub 2015 Mar 23. Review.

PMID:
25802019
24.

The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments.

Castrejon I, Carmona L, Agrinier N, Andres M, Briot K, Caron M, Christensen R, Consolaro A, Curbelo R, Ferrer M, Foltz V, Gonzalez C, Guillemin F, Machado PM, Prodinger B, Ravelli A, Scholte-Voshaar M, Uhlig T, van Tuyl LH, Zink A, Gossec L.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):910-6. Epub 2015 Mar 23. Review.

PMID:
25797345
25.

Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.

van Tuyl LH, Sadlonova M, Davis B, Flurey C, Goel N, Hewlett SE, Hill CL, Hoogland W, Kirwan JR, van Schaardenburg D, Scholte-Voshaar M, Smolen JS, Stamm T, Wells GA, Boers M.

J Rheumatol. 2016 Jan;43(1):203-7. doi: 10.3899/jrheum.141113. Epub 2015 Feb 15. Review.

PMID:
25684772
26.

Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.

Rasch LA, van Tuyl LH, Lems WF, Boers M.

Neuroimmunomodulation. 2015;22(1-2):51-6. doi: 10.1159/000362728. Epub 2014 Sep 12.

PMID:
25227967
27.

Estimation of dietary calcium intake.

Rasch LA, van Tuyl LH, de van der Schueren MA, Bultink IE, Lems WF.

Osteoporos Int. 2015 Feb;26(2):835-6. doi: 10.1007/s00198-014-2868-1. Epub 2014 Aug 30. No abstract available.

PMID:
25172383
28.

Making the invisible visible: bioelectrical impedance analysis demonstrates unfavourable body composition in rheumatoid arthritis patients in clinical practice.

Konijn NP, van Tuyl LH, Bultink IE, Lems WF, Earthman CP, van Bokhorst-de van der Schueren MA.

Scand J Rheumatol. 2014;43(4):273-8. doi: 10.3109/03009742.2013.852239. Epub 2014 Feb 7.

PMID:
24797672
29.

Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development.

Stack RJ, van Tuyl LH, Sloots M, van de Stadt LA, Hoogland W, Maat B, Mallen CD, Tiwana R, Raza K, van Schaardenburg D.

Rheumatology (Oxford). 2014 Sep;53(9):1646-53. doi: 10.1093/rheumatology/keu159. Epub 2014 Apr 11.

PMID:
24729397
30.

The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'.

van Tuyl LH, Hewlett S, Sadlonova M, Davis B, Flurey C, Hoogland W, Kirwan J, Sanderson T, van Schaardenburg D, Scholte-Voshaar M, Smolen J, Stamm T, Boers M.

Ann Rheum Dis. 2015 Jun;74(6):1004-10. doi: 10.1136/annrheumdis-2013-204798. Epub 2014 Feb 12.

PMID:
24521737
31.

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review.

van Tuyl LH, Lems WF, Boers M.

BMC Musculoskelet Disord. 2014 Jan 29;15:28. doi: 10.1186/1471-2474-15-28. Review.

32.

'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.

Jans SM, Henneman L, de Jonge A, van El CG, van Tuyl LH, Cornel MC, Lagro-Janssen AL.

Fam Pract. 2013 Oct;30(5):604-10. doi: 10.1093/fampra/cmt019. Epub 2013 Apr 29.

33.

Patient-reported remission in rheumatoid arthritis.

van Tuyl LH, Boers M.

J Rheumatol. 2013 Apr;40(4):350-2. doi: 10.3899/jrheum.130098. No abstract available.

PMID:
23547253
34.

Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias.

van Tuyl LH, van der Heijde D, Knol DL, Boers M.

Ann Rheum Dis. 2014 Feb;73(2):391-5. doi: 10.1136/annrheumdis-2012-202876. Epub 2013 Jan 24.

PMID:
23349128
35.

Body mass index measurements have limited value for the assessment of body composition in rheumatoid arthritis: comment on the article by Wolfe and Michaud.

Konijn NP, van Tuyl LH, Bultink IE, Lems WF, van Bokhorst-de van der Schueren MA.

Arthritis Care Res (Hoboken). 2013 May;65(5):833-4. doi: 10.1002/acr.21909. No abstract available.

36.

Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF, Voskuyl AE, Bultink IE.

Osteoporos Int. 2013 Jun;24(6):1827-33. doi: 10.1007/s00198-012-2157-9. Epub 2012 Oct 3.

PMID:
23052940
37.

Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis.

van Bokhorst-de van der Schueren MA, Konijn NP, Bultink IE, Lems WF, Earthman CP, van Tuyl LH.

Clin Nutr. 2012 Dec;31(6):1008-10. doi: 10.1016/j.clnu.2012.05.012. Epub 2012 Jun 12.

PMID:
22695407
38.

Patient's global assessment of disease activity: what are we measuring?

van Tuyl LH, Boers M.

Arthritis Rheum. 2012 Sep;64(9):2811-3. doi: 10.1002/art.34540. No abstract available.

39.

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis.

Klaasen R, Herenius MM, Wijbrandts CA, de Jager W, van Tuyl LH, Nurmohamed MT, Prakken BJ, Gerlag DM, Tak PP.

Ann Rheum Dis. 2012 Sep;71(9):1510-6. doi: 10.1136/annrheumdis-2011-200646. Epub 2012 Mar 22.

40.

Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.

van Tuyl LH, Britsemmer K, Wells GA, Smolen JS, Zhang B, Funovits J, van Schaardenburg D, Felson D, Boers M.

Ann Rheum Dis. 2012 Jan;71(1):33-7. doi: 10.1136/ard.2011.153742. Epub 2011 Sep 27.

PMID:
21953347
41.

Patient perspective on remission in rheumatoid arthritis.

van Tuyl LH, Smolen JS, Wells GA, Scholte-Voshaar M, Hoogland W, Boers M.

J Rheumatol. 2011 Aug;38(8):1735-8. doi: 10.3899/jrheum.110394.

PMID:
21807794
42.

[Participation of patients in medical research].

van Tuyl LH, Scholte-Voshaar MM.

Ned Tijdschr Geneeskd. 2011;155(29):A3501. Dutch.

PMID:
21791136
43.

Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria.

Britsemmer K, Ursum J, Gerritsen M, van Tuyl LH, van Schaardenburg D.

Ann Rheum Dis. 2011 Aug;70(8):1468-70. doi: 10.1136/ard.2010.148619. Epub 2011 May 17. Erratum in: Ann Rheum Dis. 2011 Nov;70(11):2060. van Tuyl, Lilian [corrected to van Tuyl, L H].

PMID:
21586440
44.

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M; American College of Rheumatology; European League Against Rheumatism.

Arthritis Rheum. 2011 Mar;63(3):573-86. doi: 10.1002/art.30129.

45.

American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M.

Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765.

PMID:
21292833
46.

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

den Uyl D, Nurmohamed MT, van Tuyl LH, Raterman HG, Lems WF.

Arthritis Res Ther. 2011 Jan 17;13(1):R5. doi: 10.1186/ar3224. Review.

47.

Progress toward the development of a new definition of remission in rheumatoid arthritis.

Boers M, Felson DT, Wells G, van Tuyl LH, Zhang B, Funovits J, Smolen J.

Bull NYU Hosp Jt Dis. 2010;68(2):140-2.

48.

Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.

van Tuyl LH, Voskuyl AE, Boers M, Geusens P, Landewé RB, Dijkmans BA, Lems WF.

Ann Rheum Dis. 2010 Sep;69(9):1623-8. doi: 10.1136/ard.2009.121764. Epub 2010 Jun 4.

PMID:
20525836
49.

Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.

van Tuyl LH, Felson DT, Wells G, Smolen J, Zhang B, Boers M; American College of Rheumatology; European League against Rheumatism Committee to Define Remission for Clinical Trials.

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):108-17. doi: 10.1002/acr.20021. Review.

50.

IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.

van Tuyl LH, Lems WF, Kerstens PJ, Voskuyl AE, Dijkmans BA, Boers M.

Ann Rheum Dis. 2009 Oct;68(10):1652-3. doi: 10.1136/ard.2008.103184. No abstract available.

PMID:
19748920

Supplemental Content

Loading ...
Support Center